Axitinib (AG-013736) With Or Without Dose Titration (Increase) In Patients With Kidney Cancer
Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
Axitinib dose titration (giving a higher dose of the drug above its standard starting dose)
among certain patients may improve the response to treatment.